Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2007122410) PYRIMIDINE DERIVATIVES AS PI3K INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2007/122410 International Application No.: PCT/GB2007/001504
Publication Date: 01.11.2007 International Filing Date: 25.04.2007
IPC:
C07D 495/04 (2006.01) ,A61K 31/519 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
495
Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
02
in which the condensed system contains two hetero rings
04
Ortho-condensed systems
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
519
ortho- or peri-condensed with heterocyclic rings
Applicants:
BAKER, Stewart, James [GB/GB]; GB (UsOnly)
GOLDSMITH, Paul, John [GB/GB]; GB (UsOnly)
HANCOX, Timothy, Colin [GB/GB]; GB (UsOnly)
PEGG, Neil, Anthony [GB/GB]; GB (UsOnly)
PRICE, Stephen [GB/GB]; GB (UsOnly)
SHUTTLEWORTH, Stephen, Joseph [GB/GB]; GB (UsOnly)
SOHAL, Sukhjit [GB/GB]; GB (UsOnly)
F.HOFFMANN-LA ROCHE AG [CH/CH]; Grenzacherstrasse 124 CH-4070 Basel, CH (AllExceptUS)
Inventors:
BAKER, Stewart, James; GB
GOLDSMITH, Paul, John; GB
HANCOX, Timothy, Colin; GB
PEGG, Neil, Anthony; GB
PRICE, Stephen; GB
SHUTTLEWORTH, Stephen, Joseph; GB
SOHAL, Sukhjit; GB
Agent:
KEEN, Celia, Mary ; J.A. Kemp & Co. 14 South Square Gray's Inn London WC1R 5JJ, GB
Priority Data:
0608264.826.04.2006GB
0608397.627.04.2006GB
Title (EN) PYRIMIDINE DERIVATIVES AS PI3K INHIBITORS
(FR) DÉRIVÉS PYRIMIDINIQUES UTILISÉS COMME INHIBITEURS DE LA PI3K
Abstract:
(EN) Thienopyrimidines of formula (Ia) or (Ib): wherein R1, R2, R3, are as defined in the claims.
(FR) L'invention concerne des thiénopyrimidines de formule (Ia) ou (Ib) : dans lesquelles R1, R2, R3 sont tels que définis dans les revendications.
front page image
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)